SEM Observation of the Filter after Administration of Blinatumomab: A Possibility of Leakage during Home Administration Using a Portable Infusion Pump

Blinatumomab (Blincyto(®) injection solution) is classified as a bispecific T-cell engaging (BiTE) antibody and is intended for the treatment of relapsed/refractory acute lymphoblastic leukemia. It requires continuous infusion to maintain therapeutic levels. Therefore, it is often administered at ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Takano, Megumi, Inoue, Motoki, Ikeda, Yuko, Kage, Hidenori, Inokawa, Tohru, Nakadate, Kazuhiko, Yasu, Takeo, Tsuda, Yasumasa, Goto, Kazumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052184/
https://www.ncbi.nlm.nih.gov/pubmed/36982821
http://dx.doi.org/10.3390/ijms24065729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052184/
https://www.ncbi.nlm.nih.gov/pubmed/36982821
http://dx.doi.org/10.3390/ijms24065729

Ejemplares similares